Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × entecavir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis B 7 Carcinoma, Hepatocellular 7 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Recurrence 1 Neoplasms 1 Lymphoma, B-Cell 1 Liver Neoplasms 1 Hepatitis B, Chronic 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Sorafenib 38 Oxaliplatin 21 Bevacizumab 21 Radiosurgery 15 Fluorouracil 15 Gemcitabine 14 Nivolumab 11 Hepatectomy 11 Cisplatin 11 lenvatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Leucovorin 9 Doxorubicin 9 durvalumab 8 Liver Transplantation 8 Blood Specimen Collection 8 atezolizumab 7 Capecitabine 7 pembrolizumab 6 camrelizumab 6 Immunohistochemistry 6 Everolimus 6 Electroporation 6 Cyclophosphamide 6 Cryosurgery 6 tremelimumab 5 sintilimab 5 apatinib 5 Sunitinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00555334 2009-04-01

LAM-RFA

Sun Yat-sen University

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡